Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 4

Ecallantide is a novel treatment for attacks of hereditary angioedema due to C1 inhibitor deficiency

Total article views   HTML views PDF downloads Totals
17,873 Dovepress* 13,010+ 2,260 15,270
PubMed Central* 4,863 711 5,574
Totals 17,873 2,971 20,844
*Since 31 May 2011
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 2 6

View citations on PubMed Central and Google Scholar